| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-10 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 9e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-05 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |